Delivery Order SPE2DB24D1205-SPE2DB25FCTDN

Award Date 1/21/25
Potential Completion Date 2/11/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,119.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range...
This federal contract award, valued at $4,027.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of INGREZZA 80 MG CAPSULE 30S, a specialty medication, to support military healthcare programs. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,106.64 Firm Fixed Price Delivery Order is for the supply of INGREZZA 40 MG CAPSULE 30S, a specialty medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $4,049.61 for the delivery of INGREZZA 60 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $14,704.48, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INGREZZA 40 MG CAPSULE 30S, a pharmaceutical product, with a completion date of January 9, 2025. The award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,049.61 firm fixed-price delivery order is for the supply of INGREZZA 60 mg capsules, a medication used for the treatment of tardive dyskinesia. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,358.65, is a delivery order for 4563458899 INGREZZA 40 MG CAPSULE 30S. It has an ultimate completion date of February 16, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is a delivery order valued at $7,106.64 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4564222276 - INGREZZA 40 MG CAPSULE 30S, with a performance period ending on April 30, 2024. The contract is a firm fixed-price arrangement and does not utilize any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $3,553.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of INGREZZA 40 MG CAPSULE 30S, a specialty pharmaceutical product, with a period of performance through November 14, 2024. The award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,027.70 firm fixed-price delivery order is for the supply of INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product, with a performance period through February 4, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCTDN
    Delivery Order

This federal contract award, valued at $4,027.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The specific contract award is for the delivery of INGREZZA 80 MG CAPSULE 30S, a medication used for the treatment of adults with tardive dyskinesia. This contract award did not have a set-aside designation, indicating open competition.

Generated 4/22/25, 9:43 AM